Breast cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with breast cancer who are treated with whole-breast radiation after breast-conserving surgery. 2) PS is from 0 to 1. 3) Patients who agreed to participate in this study.
Exclusion criteria
Exclusion criteria: 1) Patients who should be treated with a boost radiation. 2) Patients who are treated with pharmacotherapy except for hormone therapy during radiation therapy. 3) Patients who are unable to respond to self-completed questionnaires. 4) Physician decides it is inappropriate for the patient to participate in this study. 5) Patients who are going to stop radiation therapy for a long time (e.g., at the end of and the beginning of a year).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Period: Before radiation therapy, during radiation therapy (once in a week), after radiation therapy (2 and 6 weeks, 3 and 6 months, and 1 year post treatment) <Assessment by devices> Erythema & melanin index | — |
Secondary
| Measure | Time frame |
|---|---|
| Period: Before radiation therapy, during radiation therapy (once in a week), after radiation therapy (2 and 6 weeks, 3 and 6 months, and 1 year post treatment) <Assessment by devices> 1) Transepidermal water loss 2) Capacitance (stratum corneum-epidermal water) 3) Skin temperature <Visual assessment> NCI-CTC (ver.4.0 Japanese version JCOG) <Self-completed questionnaires> Skindex 29 (QOL regarding skin symptoms) | — |
Countries
Japan
Contacts
National Cancer Center Hospital Appearance Support Center